Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.53 |
| ▸ | ARG2 | P78540 | 1/20 | 0.53 |
| ▸ | ACLY | P53396 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1975908 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL22862319 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL1976899 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL19305278 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL1975910 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL18954854 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL18954850 | 1.00 | ARG1 (0.53) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL16401653 | 0.98 | ARG1 (0.55) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL18954910 | 0.98 | ARG1 (0.55) | ARG1ARG2ACLYMAPTABCC4 | |
| SCHEMBL19305277 | 0.98 | ARG1 (0.55) | ARG1ARG2ACLYMAPTABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299518-B2 | Fusion respiratory syncytial virus inhibitors and use thereof | FONDATION THE ARK (CH) | 2022-04-12 | — | — | US | disclosed |
| US-11207379-B2 | Peptides with anti-cancer activity | IDP DISCOVERY PHARMA, S.L. (ES) | 2021-12-28 | — | — | US | disclosed |
| EP-3430031-B1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP DISCOVERY PHARMA S L (ES) | 2021-10-20 | — | — | EP | disclosed |
| US-20210008159-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP DISCOVERY PHARMA S L (ES) | 2021-01-14 | — | — | US | disclosed |
| US-10639348-B2 | Peptides with anti-cancer activity | IDP DISCOVERY PHARMA, S.L. (ES) | 2020-05-05 | — | — | US | disclosed |
| US-20190083570-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP DISCOVERY PHARMA, S.L. (ES) | 2019-03-21 | — | — | US | disclosed |
| EP-3430031-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP Discovery Pharma, S.L. (ES) | 2019-01-23 | — | — | EP | disclosed |
| WO-2017157990-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP DISCOVERY PHARMA, S.L. (ES) | 2017-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210008159-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | VIP, NGLY1, LNPEP | ARG1 92/4885ARG2 288/4885ACLY 3440/4885 |
| US-20190083570-A1 | PEPTIDES WITH ANTI-CANCER ACTIVITY | VIP, NGLY1, LNPEP | ARG1 92/4885ARG2 288/4885ACLY 3440/4885 |
| US-11207379-B2 | Peptides with anti-cancer activity | VIP, NGLY1, LNPEP | ARG1 92/4885ARG2 288/4885ACLY 3440/4885 |
| US-11299518-B2 | Fusion respiratory syncytial virus inhibitors and use thereof | BST2, TMPRSS4, TMPRSS2 | ARG1 1590/4885ARG2 1157/4885ACLY 4043/4885 |
| US-10639348-B2 | Peptides with anti-cancer activity | VIP, NGLY1, LNPEP | ARG1 92/4885ARG2 288/4885ACLY 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.